News | November 03, 2021
Sun Pharma Q2FY22 PAT jumps to Rs 2088.73 Cr
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Expertise in exosomes isolation and characterization will drive innovation in this field
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
Subscribe To Our Newsletter & Stay Updated
